March 26, 2004
(The picture is different for the four-drug combination AZT + 3TC + abacavir + tenofovir, which is showing good results even though it contains one of the problematic combinations within it. The AZT helps prevent the K65R and M184V resistance pattern from developing.)
On March 31 Clinical Care Options published a half-hour training module for physicians (but available to anyone) explaining this situation, and what has been learned from it. This module, titled "Lessons Learned: The Perils of Extrapolation -- Combination NRTI Use" will be available for one year at: www.clinicaloptions.com/hiv.
Under "Treatment Update," click "Lessons Learned." Note: free one-time registration is required to use this site.
Back to the AIDS Treatment News March 26, 2004 contents page.